← EverQuote, Inc.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | ($13.8m) |
($7.1m)
+48.39%
|
($11.2m)
-57.40%
|
($19.4m)
-73.49%
|
($24.4m)
-25.64%
|
($51.3m)
-110.05%
|
$32.2m
+162.72%
|
$99.3m
+208.72%
|
— | |
| Depreciation and amortization expense | $1.3m | $2.2m | $3.4m | $5.1m | $5.8m | $6.2m | $5.7m | $3.8m | $3.4m | |
| Depreciation Amortization Depletion | — | — | — | — | $5.8m | $6.2m | $5.7m | $3.8m | $3.4m | |
| Deferred taxes | — | — | — | ($2.5m) | $0 | $0 | $0 | ($38.4m) | — | |
| Deferred Income Tax | — | — | — | — | $0 | $0 | $0 | ($38.4m) | ($30.4m) | |
| Stock-based compensation expense | $7.1m | $12.7m | $24.2m | $30.0m | $29.0m | $24.1m | $20.6m | $24.3m | $23.1m | |
| Impairment of right-of-use asset | — | — | — | — | — | $384k | — | — | — | |
| Asset Impairment Charge | — | — | — | — | $0 | $384k | $0 | $0 | $0 | |
| Change In Working Capital | — | — | — | — | ($22.8m) | ($1.7m) | $8.1m | ($1.6m) | ($9.9m) | |
| Accounts receivable | ($2.8m) | ($15.2m) | ($14.0m) | $10.5m | $5.4m | $8.2m | ($40.2m) | ($13.8m) | ($21.1m) | |
| Change In Receivables | — | — | — | — | ($18.9m) | $12.4m | ($35.3m) | ($11.9m) | ($21.1m) | |
| Changes In Account Receivables | — | — | — | — | $5.4m | $8.2m | ($40.2m) | ($13.8m) | ($21.1m) | |
| Accounts payable | $4.9m | $6.8m | $9.3m | ($4.0m) | $1.1m | ($13.4m) | $42.7m | $16.9m | $11.3m | |
| Acquisition of property and equipment included in accounts payable | $3.7m | $3.0m | $3.8m | $100k | $60k | $25k | $135k | $125k | — | |
| Change In Payables And Accrued Expense | — | — | — | — | ($1.3m) | ($15.0m) | $43.7m | $14.8m | $11.3m | |
| Accrued expenses and other current liabilities | $1.3m | $10.1m | ($4.0m) | $2.7m | ($2.4m) | ($1.5m) | $1.0m | ($2.1m) | — | |
| Deferred revenue | $454k | $61k | $368k | $227k | ($229k) | $5k | ($107k) | ($103k) | — | |
| Change In Accrued Expense | — | — | — | — | ($2.4m) | ($1.5m) | $1.0m | ($2.1m) | $2.6m | |
| Prepaid expenses and other current assets | ($863k) | ($5.6m) | $623k | ($3.6m) | ($2.1m) | $962k | $440k | ($4.4m) | — | |
| Other assets | — | ($1k) | ($554k) | ($10.9m) | ($19k) | $421k | ($291k) | $137k | — | |
| Change In Other Current Assets | — | — | — | — | $2.6m | $2.9m | $1.9m | $1.3m | $1.3m | |
| Change In Other Current Liabilities | — | — | — | — | ($2.9m) | ($3.0m) | ($2.5m) | ($1.1m) | ($1.2m) | |
| Net cash provided by (used in) operating activities | ($1.9m) |
$4.4m
+332.63%
|
$10.7m
+141.74%
|
$7.2m
-32.61%
|
($15.8m)
-319.66%
|
($2.8m)
+82.09%
|
$66.6m
+2453.82%
|
$95.4m
+43.29%
|
$100.7m
+5.58%
|
|
| Acquisition of property and equipment, including costs capitalized for development of internal-use software | ($3.7m) | ($3.0m) | ($3.8m) | ($2.9m) | ($4.3m) | ($3.8m) | ($4.1m) | ($5.1m) | — | |
| Capital Expenditure | — | — | — | — | ($4.3m) | ($3.8m) | ($4.1m) | ($5.1m) | ($5.6m) | |
| Net cash provided by (used in) investing activities | ($3.7m) | ($3.0m) | ($18.8m) | ($18.8m) | ($4.3m) | $9.4m | ($4.1m) | ($5.1m) | ($5.6m) | |
| Provision for bad debt | — | $478k | $105k | ($41k) | $693k | $204k | $13k | $10k | — | |
| Repurchase of common stock | — | — | — | — | — | — | — | ($21.0m) | — | |
| Proceeds from private placement of common stock | — | — | — | — | $15.0m | — | — | — | — | |
| Issuance of Class A common stock | — | — | — | — | $2.1m | — | — | — | — | |
| Common Stock Issuance | — | — | — | $0 | $15.0m | $0 | $0 | ($21.0m) | $0 | |
| Common Stock Payments | — | — | — | — | — | $0 | $0 | ($21.0m) | ($50.0m) | |
| Issuance Of Capital Stock | — | — | — | $0 | $15.0m | $0 | $0 | — | $0 | |
| Repurchase Of Capital Stock | — | — | — | — | — | $0 | $0 | ($21.0m) | ($50.0m) | |
| Tax withholding payments related to net share settlement | — | — | — | — | ($100k) | ($402k) | ($1.8m) | ($4.0m) | — | |
| Net Other Financing Charges | — | — | — | — | ($100k) | ($402k) | ($1.8m) | ($4.0m) | ($3.6m) | |
| Net cash provided by (used in) financing activities | $44.8m |
$3.0m
-93.35%
|
$4.9m
+64.55%
|
$3.6m
-26.33%
|
$15.8m
+338.23%
|
$577k
-96.36%
|
$1.7m
+195.84%
|
($21.1m)
-1333.98%
|
($51.0m)
-142.13%
|
|
| Cash, cash equivalents and restricted cash at beginning of period | $41.9m | $46.3m | $43.1m | $35.1m | $30.8m | $38.0m | $102.1m | $171.4m | — | |
| Beginning Cash Position | — | — | — | — | $35.1m | $30.8m | $38.0m | $102.1m | $148.2m | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | — | — | ($7k) | ($6k) | ($27k) | $18k | $1k | $3k | ($3k) | |
| Net increase in cash, cash equivalents and restricted cash | $39.3m | $4.4m | ($3.2m) | ($8.0m) | ($4.3m) | $7.1m | $64.2m | $69.3m | — | |
| Additional Supplementary Disclosures | ||||||||||
| Additional Supplementary Disclosures | ||||||||||
| Loss on sale of health assets | — | — | — | — | — | $19.4m | — | — | — | |
| Change in fair value of contingent consideration liabilities | — | — | $1.8m | $196k | ($4.1m) | ($150k) | — | — | — | |
| Unrealized foreign currency transaction (gains) losses | — | — | — | $24k | ($9k) | $21k | ($26k) | $110k | — | |
| Litigation accrual settled with sale of assets | — | — | — | — | — | — | — | $7.8m | — | |
| Commissions receivable, current and non-current | — | — | ($5.8m) | ($16.9m) | ($24.2m) | $4.2m | $4.9m | $1.9m | — | |
| Operating lease right-of-use assets | — | — | $2.1m | $2.7m | $2.6m | $2.5m | $2.2m | $1.1m | — | |
| Operating lease liabilities | — | — | ($2.2m) | ($2.8m) | ($2.9m) | ($3.0m) | ($2.5m) | ($1.1m) | — | |
| Proceeds from sale of health assets | — | — | — | — | — | $13.2m | — | — | — | |
| Proceeds from exercise of stock options | $861k | $3.0m | $4.9m | $3.6m | $942k | $979k | $3.6m | $3.9m | — | |
| Assets sold in settlement of litigation accrual | — | — | — | — | — | — | — | $8.1m | — | |
| Operating lease liabilities arising from obtaining right-of-use assets | — | — | $541k | $383k | $1.1m | $0 | $4.0m | $0 | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | $15.8m | $577k | $1.7m | ($21.1m) | ($51.0m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | ($4.3m) | $9.4m | ($4.1m) | ($5.1m) | ($5.6m) | |
| Change In Account Payable | — | — | — | — | $1.1m | ($13.4m) | $42.7m | $16.9m | $11.3m | |
| Change In Cash Supplemental As Reported | — | — | — | — | ($4.3m) | $7.1m | $64.2m | $69.3m | — | |
| Change In Other Working Capital | — | — | — | — | ($229k) | $5k | ($107k) | ($103k) | $179k | |
| Change In Payable | — | — | — | — | $1.1m | ($13.4m) | $42.7m | $16.9m | $11.3m | |
| Change In Prepaid Assets | — | — | — | — | ($2.1m) | $962k | $440k | ($4.4m) | ($3.0m) | |
| Changes In Cash | — | — | — | — | ($4.2m) | $7.1m | $64.2m | $69.3m | $44.1m | |
| End Cash Position | — | — | — | — | $30.8m | $38.0m | $102.1m | $171.4m | $192.3m | |
| Financing Cash Flow | — | — | — | — | $15.8m |
$577k
-96.36%
|
$1.7m
+195.84%
|
($21.1m)
-1333.98%
|
($51.0m)
-142.13%
|
|
| Free Cash Flow | — | — | — | — | ($20.1m) | ($6.7m) | $62.5m | $90.3m | $95.1m | |
| Income Tax Paid Supplemental Data | — | — | — | — | $175k | $589k | $2.3m | — | $2.3m | |
| Investing Cash Flow | — | — | — | — | ($4.3m) | $9.4m | ($4.1m) | ($5.1m) | ($5.6m) | |
| Net Business Purchase And Sale | — | — | — | ($16.0m) | $0 | $0 | — | — | — | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | — | ($9k) | $21k | ($26k) | $110k | ($37k) | |
| Net PPE Purchase And Sale | — | — | — | — | ($4.3m) | ($3.8m) | ($4.1m) | ($5.1m) | ($5.6m) | |
| Operating Gains Losses | — | — | — | — | ($9k) | $19.4m | ($26k) | $110k | ($37k) | |
| Other Non Cash Items | — | — | — | $196k | ($4.1m) | ($150k) | — | $7.8m | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | $942k | $979k | $3.6m | $3.9m | $2.6m | |
| Provisionand Write Offof Assets | — | — | — | — | $693k | $204k | $13k | $10k | $5k | |
| Purchase Of Business | — | — | — | ($16.0m) | $0 | $0 | — | — | — | |
| Purchase Of PPE | $3.7m | $3.0m | $3.8m | $2.9m | ($4.3m) | ($3.8m) | ($4.1m) | ($5.1m) | ($5.6m) | |
| Stock Based Compensation | — | — | — | — | $29.0m | $24.1m | $20.6m | $24.3m | $23.1m |